US Material Events SEC 8-K Filings — October 29, 2026

29-10-2026

Freedom Holding Corp. (FRHC) entered into a material investment agreement on October 23, 2026 with Kokzhiyek Fund LP, through its wholly-owned AIFC subsidiary FRHC-IF.SPC Ltd., under which the Fund will subscribe for U.S. dollar-denominated bonds of up to $1.16B (5-year maturity, 7.8% coupon, paid semi-annually) listed on the Astana International Exchange, with proceeds restricted to seven specified projects (data centers, AI supercluster, telecom, media, urban technology, cross-border trade). The bonds are guaranteed by the Company, Freedom Kazakhstan Ltd., and CEO/majority shareholder Timur Turlov, and carry significant covenants, pledges, and a contingent right for the Fund to receive common stock if coupons go unpaid, creating potential dilution and governance implications.

• · Bond proceeds may be held in USD or Kazakhstan tenge and released in stages; availability period ends December 30, 2028 (extendable at Issuer's request), with unused proceeds subject to mandatory redemption.
• · Fund may claim Company common stock if coupon is unpaid for 90 days, but only between the second and fourth anniversary of its initial purchase and only for unpaid interest, not principal.
• · Events of default include loss of Turlov's shareholding without Fund consent, sanctions listing of the Company or Turlov, collateral seizure or invalidation, and obstruction of the Fund's share-issuance right.
• · Required Project collateral includes pledges over 100% of each Project Company's equity, claims under concession contracts, land and fixed assets, plus Project Company guarantees capped at allocated financing plus interest.
• · Any Project cost overruns or currency-driven funding shortfalls must be covered by the Company, Issuer, or Project Companies without additional Fund funding.
• · Restrictions on dividends by the Issuer and Project Companies, additional indebtedness, asset dispositions, and related-party transactions apply under the agreements.
• · Bonds and any Shares are unregistered under the Securities Act (Section 4(a)(2) / Regulation S); no underwriter or underwriting discounts are involved.
• · The Company intends to file the agreements as exhibits to its Form 10-Q for the quarter ending December 31, 2026, with certain confidential information redacted under Item 601(b)(10)(iv) of Regulation S-K.

29-10-2026

Aehr Test Systems expanded its board from six to seven directors and appointed Narsing Vijayrao, a former Meta Platforms VP of Infrastructure with roughly 30 years of semiconductor and AI infrastructure experience, effective October 28, 2026. He will serve on the Compensation Committee and qualifies as independent under Nasdaq standards. As a non-employee director he receives a $65,000 annual cash retainer plus $140,000 in initial RSUs vesting over four years (1/16th quarterly), with future annual RSU grants of $140,000 vesting over one year.

• · Board appointment effective October 28, 2026; 8-K filed October 29, 2026
• · Vijayrao served as VP of Infrastructure at Meta Platforms from April 2013 to August 2026
• · Previously held leadership roles at AMD from October 2003 to February 2013, including technologist in the Office of the CTO
• · Holds a Master of Science in Electrical & Computer Engineering from Purdue University
• · No arrangements or understandings with any other person regarding his selection; no Item 404(a) related-party transactions
• · Will serve until the Company's next annual meeting of shareholders
• · Will enter into the Company's standard indemnification agreement

29-10-2026

UMB Financial Corp disclosed in an 8-K that effective October 28, 2026, Shannon A. Johnson will devote her full attention to her role as Chief Risk Officer, dropping the title of Chief Administrative Officer. The CAO role will not be filled, with former administrative responsibilities absorbed within existing management; the company stated the change does not reflect any disagreement and Johnson remains employed. No financial figures, compensation changes, or quantitative metrics were disclosed.

• · Effective date of the officer title change: October 28, 2026; 8-K filed October 29, 2026
• · The Chief Administrative Officer position will not be filled; administrative duties reassumed within existing management
• · Company explicitly states the change does not reflect any disagreement on operations, policies, or practices
• · Item 5.02 information is furnished, not filed, and not incorporated by reference into other filings
• · Commission File Number 001-38481; incorporated in Missouri; IRS EIN 43-0903811; headquarters at 1010 Grand Blvd., Kansas City, MO 64106
• · Preferred Series B carries a 7.750% fixed-rate reset non-cumulative perpetual dividend rate

29-10-2026

General Motors disclosed in an 8-K that Christopher T. Hatto, Vice President, Global Business Solutions and Chief Accounting Officer, notified the company on October 23, 2026 of his decision to retire effective April 1, 2027. GM stated the retirement is not the result of any disagreement over operations, policies or practices, and Hatto will remain principal accounting officer through the Retirement Date to support an orderly transition. A successor principal accounting officer will be announced at a later date.

• · Date of earliest event reported: October 23, 2026; 8-K filing date: October 29, 2026
• · Retirement Date set for April 1, 2027
• · Hatto will continue serving as principal accounting officer through the Retirement Date
• · Successor principal accounting officer appointment to be announced at a later date
• · Filing signed by John S. Kim, Assistant Corporate Secretary
• · Company incorporated in Delaware; IRS Employer Identification No. 27-0756180; Commission File Number 001-34960
• · Principal executive offices at 1240 Woodward Avenue, Detroit, Michigan 48265

29-10-2026

Bristol Myers Squibb notified Prothena on October 28, 2026 that it will not advance PRX019 further in the clinic, terminating the May 2024 exclusive global license agreement effective January 28, 2027. Prothena had received an $80 million upfront payment and was eligible for up to $617.5 million in milestones plus tiered royalties, none of which BMS will now owe. However, BMS continues developing moponetug (formerly PRX005) for Alzheimer's disease, having paid $135 million in licensing payments to date with up to $562.5 million in remaining milestones plus royalties still in play.

• · PRX019 Phase 1 trial, completed in first half of 2026, demonstrated benign safety and tolerability, no immunogenicity, and dose-dependent pharmacokinetics/pharmacodynamics meeting prespecified targets
• · PRX019 license agreement terminates January 28, 2027
• · Moponetug targets a key epitope within the microtubule binding region (MTBR) of tau for Alzheimer's disease
• · Moponetug and PRX019 both originated from the 2018 BMS R&D collaboration
• · Prothena ordinary shares trade on Nasdaq Global Select Market under PRTA, par value $0.01 per share

29-10-2026

Strategy Inc reported Q3 2026 operating income of $20.91 billion (vs $3.89 billion in Q3 2025), driven almost entirely by a $20.91 billion gain on digital assets, with net income of $19.53 billion and diluted EPS of $44.75 (vs $8.42 prior year). However, core software revenue declined 3% YoY to $125.4 million from $128.7 million, and BTC Yield was negative at (3.7)% YTD with a BTC $ Gain of $(2.03) billion, reflecting a challenging bitcoin market. The company also announced CFO Andrew Kang will step down effective November 5, 2026, with CEO Phong Le serving as principal financial officer until Reza Virasteh becomes CFO on January 1, 2027.

• · BTC Gain of (24,947) YTD 2026 and BTC $ Gain of $(2.03) billion based on October 23, 2026 bitcoin price of $81,200
• · Average cost per bitcoin of approximately $75,446 vs market price of approximately $81,200
• · STRC repurchased 20,980,508 shares at average price of $97.39, a 2.6% discount to $100 stated amount
• · USD Assets provide approximately 3.4 years of coverage on dividend and interest obligations
• · STRC upgraded to daily dividends starting November 1, 2026; STRF, STRK, STRD to daily dividends starting January 1, 2027
• · Company expects preferred distributions to be treated as non-taxable return of capital (ROC) for ten years or more
• · No repurchases under the $1.0 billion MSTR repurchase program to date
• · Board authorization to sell bitcoin to fund USD Reserve up to $1.25 billion of bitcoin sales
• · Andrew Kang steps down as CFO effective November 5, 2026, remaining as advisor through December 31, 2026
• · Reza Virasteh becomes EVP and CFO effective January 1, 2027, serving as co-principal financial officer alongside Phong Le
• · Strategy is the 4th largest equity issuer in the U.S. with $21.23 billion raised YTD
• · Conference call scheduled October 29, 2026 at 5:00 p.m. ET

29-10-2026

FOXO Technologies Inc. (OTC: FOXO) announced it has entered into Stock Purchase Agreements to acquire preferred stock of Ludwig Enterprises, Inc. (OTC: LUDG) carrying a majority of Ludwig's voting power, plus a Note Purchase Agreement to buy certain Ludwig notes from Thomas E. Terwilliger. The deals have NOT closed and remain subject to conditions including Nasdaq listing approval for FOXO's common stock, completion of a satisfactory financing, due diligence, and simultaneous closing; sellers may terminate if Nasdaq listing and related public offering are not completed within 120 days of signing. Ludwig's lead asset, the Revealia mRNA buccal swab platform, has not been FDA approved or cleared and has not been commercialized, and FOXO has a history of losses with no assurance the transactions or financing will be completed.

• · Revealia is associated with international patent application published as WO2024064751 (PCT/US23/74690)
• · Ludwig Enterprises, Inc. is a Nevada corporation with common stock quoted under symbol LUDG
• · FOXO common stock is currently quoted on OTC under symbol FOXO
• · Selling stockholders granted FOXO irrevocable proxies to vote the applicable Ludwig preferred shares, subject to voting agreement terms and limitations; sellers retain ownership of the preferred shares until closing
• · Big South Fork Medical Center is a critical access designated (CAH) hospital in East Tennessee
• · FOXO disclosed a history of losses and may not achieve or maintain profitability
• · Contact: Sebastien Sainsbury, ssainsbury@foxotechnologies.com, (561) 485-0151

29-10-2026

Ionetix Corporation disclosed a series of compensation actions approved on October 23, 2026: stock option grants to CEO Kevin Cameron (1,025,600 shares) and CFO Phieu Phun (854,700 shares) at a $3.00 exercise price, adoption of a Non-Employee Director Compensation Plan with equity awards to four directors, and an Annual Performance Bonus Plan for subsidiary employees. Notably, the Director Compensation Plan provides no cash retainers, and the CEO and CFO are excluded from the Bonus Plan, while the Bonus Plan requires achievement of at least 80% of corporate goals before any bonuses are earned.

• · Options vest 25% on first anniversary and 1/36th monthly thereafter over 36 months, expiring 10 years from grant
• · Employment agreements dated April 1, 2026 provide full vesting acceleration upon Involuntary Separation or qualifying termination in connection with a Change of Control
• · Director Compensation Plan provides no cash retainers; initial option awards vest over four years, annual option awards vest on first anniversary, RSUs vest January 1 of the following year
• · All outstanding director awards fully vest upon a change in control
• · Bonus Plan effective for 2026 calendar year and each subsequent year until amended or terminated
• · Company is an emerging growth company; securities registered: None; trading symbol: None
• · Company formerly named JDEV Acquisition Corp, name changed January 28, 2026

29-10-2026

Monolithic Power Systems reported record Q3 2026 revenue of $1,202.4M, up 22.6% QoQ and 63.1% YoY, crossing $1 billion quarterly revenue for the first time, driven by Enterprise Data (+33.2% QoQ, +164.6% YoY to $506.7M) and Communications (+42.5% QoQ, +134.7% YoY). However, Storage & Computing revenue declined 3.8% QoQ to $192.2M and Consumer fell 11.6% YoY to $64.0M, while GAAP operating margin slipped 1.3 pts QoQ to 29.7% on a 29.8% jump in opex. GAAP net income rose 5.4% QoQ and 50.8% YoY to $271.1M ($5.51 diluted EPS), and the company guided Q4 revenue to $1,315M-$1,385M while authorizing an additional $500M buyback.

• · Q4 2026 guidance: GAAP gross margin 55.2%-55.8%, non-GAAP gross margin 55.5%-56.1%
• · Q4 2026 GAAP opex guidance $334.0M-$342.0M; non-GAAP opex $216.8M-$220.8M
• · Q4 2026 stock-based compensation guidance $121.0M-$125.0M
• · Q4 2026 fully diluted shares guidance 48.9-49.3 million
• · Cash declined to $1,091.2M from $1,413.8M QoQ, partly reflecting $453.4M of Q3 buybacks
• · Accounts receivable rose to $461.6M from $343.6M QoQ; DSO increased 3 days to 35
• · Internal inventories rose to $764.9M from $675.8M QoQ
• · Stock-based compensation more than doubled QoQ to $106.3M from $53.5M
• · Non-GAAP tax rate flat at 15%
• · Enterprise Data rose to 42.1% of revenue from 38.8% QoQ; Storage & Computing fell to 16.0% from 20.4%

29-10-2026

Marathon Petroleum Corp (NYSE: MPC) announced the election of David E. Constable, former Chairman and CEO of Fluor Corporation, to its board of directors effective March 1, 2027, expanding the board to 11 directors. Constable brings over four decades of leadership experience across energy, chemicals, engineering and construction, including prior CEO roles at Fluor and Sasol Ltd. The appointment is a routine governance update with no financial figures or performance metrics disclosed.

• · Constable's board term is effective March 1, 2027, roughly four months after the October 29, 2026 announcement
• · Constable previously served on the boards of Anadarko Petroleum and Rio Tinto and currently serves on the board of ABB Ltd
• · Constable graduated from the University of Alberta with a civil engineering degree and completed Thunderbird's International Management Program and Wharton's Advanced Management Program
• · Constable is a longstanding member of the U.S. Business Council
• · MPC describes itself as operating the nation's largest refining system and owns the general partner and majority limited partner interest in MPLX LP
• · Investor Relations contact number is (419) 421-2071; media contact number is (419) 421-3577

29-10-2026

Teva Pharmaceutical Industries elected Dr. David J. Brailer to its Board of Directors effective November 3, 2026, serving until the 2027 annual shareholder meeting. The Board determined Dr. Brailer qualifies as an independent director under NYSE listing rules, and he is expected to join the Human Resources and Compensation and Compliance Committees. Dr. Brailer brings extensive health-tech and payer experience, having served as Chief Health Officer of The Cigna Group (2022-2026) and currently as Chairman and CEO of medem.ai.

• · Dr. Brailer's election is effective November 3, 2026, and runs until Teva's 2027 annual meeting of shareholders
• · Dr. Brailer has served as Chairman and CEO of medem.ai since 2024
• · He was Founder and Executive Chairman of Health Evolution since 2010 and Founder and Managing Partner of Health Evolution Partners since 2007
• · He served as Chief Health Officer of The Cigna Group from 2022 to 2026 and as its Chief Transformation Officer from 2024 to 2026
• · He has been Vice Chairman of the Duke Margolis Health Policy Institute since 2021
• · He previously served on boards of Prolacta Bioscience (2012-2023) and Walgreens Boots Alliance (2012-2021)
• · He holds a Ph.D. in Management Science and Applied Economics from The Wharton School and an M.D. with honors and B.S. cum laude from West Virginia University
• · He will receive the same compensation as other non-executive directors, per the definitive proxy statement filed March 31, 2026
• · No arrangements or understandings exist between Dr. Brailer and other persons regarding his election, and no related party transactions or family relationships were disclosed

29-10-2026

Dror Ortho-Design, Inc. entered into a Securities Purchase Agreement on October 29, 2026, raising $245,000 in aggregate principal through 0% interest Debentures due December 31, 2026, in a private placement exempt under Section 4(a)(2)/Regulation D. The Debentures automatically convert into common stock at the Public Offering price if a public offering closes before maturity, with accompanying Purchase and Additional Warrants (150% of Debenture Shares if debentures remain outstanding, otherwise 100%). Separately, holders of $2,400,000 in Prior Debentures issued between June 5, 2025 and August 19, 2026 elected to extend maturities to December 31, 2026, with no other terms modified.

• · Debenture holders may extend the Maturity Date in 60-day increments upon written notice to the Company.
• · Warrants, if issued, are exercisable immediately at the Public Offering per-share price and expire five years from issuance; no public trading market exists for the Warrants.
• · The Company may prepay all or a portion of outstanding Debenture principal prior to maturity, subject to prior notice to holders.
• · Extension Notices for Prior Debentures are effective as of June 30, 2026, October 19, 2026, or October 31, 2026, as applicable.
• · The Company's principal executive offices are at Shatner Street 3, Jerusalem, Israel; it is a Delaware corporation (CIK 0001282980).
• · Exhibits filed: 4.1 Form of Debenture, 4.2 Form of Warrant, 10.1 Form of Securities Purchase Agreement, 104 Cover Page XBRL.

29-10-2026

Zoomcar Holdings closed the seventh tranche of its Series A unit private placement on October 23, 2026, issuing 75 Units (75 Series A Convertible Preferred Shares plus 75 warrants for 1,500,000 common shares) at $1,000 per Unit for gross proceeds of approximately $75,000, part of an offering of up to $5,000,000 (plus $5,000,000 overallotment). However, the deal triggered price-reset/anti-dilution provisions that cut the Preferred conversion price from $0.05 to $0.0116 and the warrant exercise price from $0.0625 to $0.0116, making each Preferred Share convertible into 86,206 common shares (up from 20,000) — a roughly 331% increase in dilution that the company itself calls substantially dilutive to common holders. Separately, on September 22, 2026 OTC Markets notified the company that its public float fell below the 10% OTCQB minimum, giving a 90-day cure period through December 21, 2026, with risk of removal from the OTCQB Venture Market if not remedied.

• · Offering termination date extended to November 16, 2026, and may be further extended
• · Registration statement for resale must be filed within 15 calendar days of the Seventh Closing; partial liquidated damages apply for failure
• · Subscription funds held in escrow with CSC Delaware Trust Company pending closing
• · Warrants exercisable immediately and expire five years from issuance
• · Number of shares issuable does not give effect to the reverse stock split approved by stockholders on August 11, 2026
• · Warrant share count was NOT increased by the exercise-price reset
• · Board approved the reset and directed the transfer agent to reserve sufficient shares for full conversion/exercise
• · John Clarke recused himself and abstained from voting on the Placement Agent Agreement under DGCL Section 144
• · OTC Markets notice received September 22, 2026; company intends to submit a written cure plan and request an extension
• · Common Stock is not listed on any national securities exchange; OTC notice does not affect business operations or Exchange Act reporting obligations

29-10-2026

Estrella Immunopharma appointed Cynthia Pussinen as CEO, Class I director and Chairperson effective October 25, 2026, while founder Cheng Liu transitioned from CEO to Chief Scientific Officer, remaining President and a director. Pussinen receives a $250,000 base salary that steps up to $400,000, $450,000 and $525,000 upon cumulative qualifying funding exceeding $35.0M, $55.0M and $75.0M, plus a 1,000,000-share option and a 60% target bonus for 2026. However, the company continues to defer base salaries of Liu and CFO Peter Xu without interest pending additional financing, signaling ongoing liquidity constraints; the Board also proposed declassifying its staggered board for a 2027 stockholder vote.

• · Pussinen, age 57, was Managing Director, Biotech Investments at Sorbie Bornholm Ltd. from March 2026 to October 2026
• · Pussinen was CEO and director of Sernova Corp. from August 2023 to August 2024 and CTO of Spark Therapeutics from January 2021 to November 2022
• · Pussinen's principal work location is Connecticut with remote/hybrid work permitted; no relocation required
• · Option grant occurs on the second business day after the 8-K filing, with exercise price equal to the Nasdaq closing price on grant date
• · Amendments to Liu's and Xu's employment agreements conform their salary, bonus, benefits and severance terms to Pussinen's, with no new equity awards
• · Base salaries of Liu and Xu remain deferred without interest pending completion of additional financing
• · Board resolved not to leave any class of directors unoccupied and to submit the declassification amendment at each subsequent annual meeting until approved if rejected in 2027
• · Company is an emerging growth company; common stock and warrants trade on Nasdaq under ESLA and ESLAW

29-10-2026

ADTRAN Holdings appointed Dr. Christian H. Terlinde as an independent member of its Board of Directors, effective October 27, 2026. Terlinde brings over two decades of senior financial leadership, currently serving as Group CFO of Flender International GmbH and previously as Group CFO of publicly traded JOST Werke SE. The filing contains no financial results or performance metrics, so no period-over-period comparisons are applicable.

• · Appointment effective October 27, 2026; announcement dated October 29, 2026
• · Dr. Terlinde holds a doctorate in business administration (magna cum laude) and graduate and undergraduate degrees from the University of Duisburg-Essen
• · Completed executive education at the University of St. Gallen and has taught U.S. GAAP, IFRS, and German GAAP at the university level
• · Serves on the examination board for German Certified Public Accountants
• · ADTRAN Holdings trades on NASDAQ (ADTN) and Frankfurt Stock Exchange (FSE: QH9)
• · ADTRAN Holdings is the majority shareholder of Adtran Networks SE (formerly ADVA Optical Networking SE)

29-10-2026

Aldel Financial II Inc., a Cayman Islands SPAC, entered into a non-interest-bearing promissory note dated October 23, 2026 with affiliate Aldel Investors II LLC (both controlled by CEO Robert I. Kauffman) for up to $1,000,000. Proceeds are for working capital, including trust-account extension payments, drawn in minimum increments of $50,000 with a five-business-day funding window. The note carries no interest, is repayable after an initial business combination, and the payee waives all claims to the IPO trust account — a related-party financing that extends the SPAC's runway but signals reliance on insider capital rather than external funding.

• · Note is dated as of October 23, 2026, the same date as the IPO and concurrent private placement consummated in 2024
• · Drawdowns are irrevocable — once drawn, amounts are unavailable for future requests even if prepaid
• · Payee waives any right, title, interest or claim to amounts in the IPO trust account
• · Note is governed by New York law with exclusive New York court jurisdiction
• · Events of Default include failure to pay principal within five business days and voluntary/involuntary bankruptcy proceedings
• · Note may be prepaid at any time without penalty
• · Assignment requires prior written consent of the other party

29-10-2026

Coastal Financial Corporation (CCB) disclosed that Brian Hamilton, President of CCBX, will transition from his employee role to a consulting arrangement after the technology and infrastructure initiatives he led substantially progressed. The consulting engagement runs through May 1, 2027 at $35,000 per month, capped at $245,000. Separately, CEO Eric M. Sprink voluntarily reduced his annual base salary from $874,000 to $500,000 as part of a broader profit improvement and cost-reduction plan.

• · Hamilton's consulting agreement includes customary releases and continuing confidentiality, non-solicitation, non-competition, non-disparagement and cooperation obligations
• · Hamilton will remain a member of the Company's Board of Directors
• · Hamilton will provide strategic advisory and business development services to the CEO on an as-needed basis through May 1, 2027
• · Hamilton's consulting agreement and the CEO employment agreement amendment will be filed with the Form 10-Q for the quarter ending September 30, 2026
• · The CEO reduced his compensation voluntarily

29-10-2026

Kiora Pharmaceuticals in-licensed KIO-401 (mitucapistat), an oral calpain inhibitor for central retinal artery occlusion (CRAO) and planned for NAION, from Senju Pharmaceutical for ex-Asia rights, with a $3.5 million upfront payment and a low-teens-million milestone upon technology transfer expected in 2027. Kiora plans a multinational Phase 3 CRAO trial targeting 2027 initiation, subject to funding and regulatory alignment, and a Phase 2b NAION study targeting 2028. The company is evaluating financing alternatives and discontinuing development of KIO-104, while the asset's support rests on Japanese Phase 2a and Phase 3 data that remain unproven in a larger, controlled setting.

• · Phase 3 CRAO trial estimated sample size exceeds 100 patients; final design, endpoints and enrollment criteria pending regulatory discussions
• · Japanese Phase 2a showed statistically significant ETDRS visual acuity improvement versus a prospective observational registry (p=0.0398), a non-randomized external comparator rather than concurrent controls
• · Japanese Phase 3 showed BCVA improvement, including a statistically significant subgroup of patients legally blind at baseline (p=0.0195)
• · KIO-104 development discontinued; KLARITY trial data from enrolled patients to be reported and out-licensing considered
• · Financing for KIO-401 late-stage development is not yet secured; company is evaluating alternatives, implying dilution risk
• · Glaucoma identified as a potential additional indication requiring further preclinical and clinical evaluation
• · Ticker discrepancy: release references NASDAQ: KPRX while the filing security is KPHMW

29-10-2026

New Era Energy & Digital (NUAI) announced a $64 million private investment in public equity (PIPE) at $2.75 per share, issuing 23,272,727 common shares, with closing expected October 30, 2026. Proceeds will repay recent Macquarie facility borrowings, fund working capital, and support leasing negotiations for 757 MW across Phases 1 and 2 at Texas Critical Data Centers. The securities are unregistered and the company agreed to file a resale registration statement, which introduces dilution and near-term financing pressure in a self-described challenging market.

• · Proceeds to repay recent borrowings under the Macquarie facility, with remainder for working capital and general corporate purposes
• · Shares are unregistered under the Securities Act; a resale registration statement must be filed with the SEC under a registration rights agreement
• · Management states that post-closing the company will hold a strong net cash position
• · Phase 1 power is described as secured and fully funded, with delivery expected in Q3 2027
• · Management describes the raise as necessary to meet near-term financing needs in a challenging market, and the filing flags going-concern and access-to-capital risks

29-10-2026

Synaptics held its 2026 Annual Meeting of Stockholders on October 27, 2026, with 91.04% of the 39,692,413 eligible shares present. Stockholders elected all eight directors, ratified KPMG LLP as independent auditor for fiscal 2026, and approved an amendment adding 1,000,000 shares to the Amended and Restated 2019 Equity and Incentive Compensation Plan, though the plan vote was far less decisive than the others. Stockholders also approved, on an advisory basis, the compensation of named executive officers.

• · Patricia Kummrow received about 2.38 million AGAINST votes, roughly 7.8% of votes cast, far higher than the sub-1% AGAINST votes recorded for most other directors, signalling notable investor dissent on her election.
• · The Equity Plan amendment drew about 8.97 million AGAINST votes, roughly 27% of votes cast, the largest opposition of any proposal and a meaningful signal of shareholder concern over dilution or plan terms.
• · The Equity Plan was approved by the Board on July 28, 2026, and the full terms are in the Proxy Statement filed September 15, 2026 and Exhibit 10.1 to this 8-K.

29-10-2026

Forestar Group announced that Donald J. Tomnitz will retire as Executive Chairman effective October 31, 2026, remaining in a two-year consulting role. Anthony W. Oxley, current President and CEO since January 2024, will assume the additional role of Executive Chairman effective November 1, 2026. The filing contains no quantitative performance comparisons; the company reports delivering more than 13,400 residential lots in the twelve months ended June 30, 2026.

• · Tomnitz's retirement is effective October 31, 2026; Oxley's added Executive Chairman role takes effect November 1, 2026.
• · Forestar is a majority-owned subsidiary of D.R. Horton, Inc., the largest U.S. homebuilder by volume since 2002.
• · Oxley has led the company as President and CEO since January 2024.

29-10-2026

Bandwidth Inc. (NASDAQ: BAND) announced that its board elected Chip Schroeder, a former Silver Lake managing director, as a director effective October 28, 2026, expanding the board to six members, four of whom are independent. The appointment is a governance addition rather than a financial disclosure, and the release contains no reported financial results, guidance, or performance metrics.

• · Schroeder spent more than a decade at Silver Lake, rising to managing director, and previously served on the boards of Blackhawk Network, Cast & Crew, Clubessential Holdings, Oak View Group and Shadowbox Studios
• · Schroeder's background spans go-to-market, corporate strategy and capital markets experience across digital infrastructure, fintech, software and entertainment
• · Schroeder holds a B.A. in History from Stanford University

29-10-2026

Harley-Davidson reported Q3 2026 results and raised full-year 2026 HDMC and HDFS guidance for the second time this year. North American retail sales of new motorcycles rose 9% YoY, the fourth consecutive quarter of growth, while global retail rose 5%. However, HDMC revenue fell 10% to $964 million on lower shipments, HDMC operating income dropped 18% YoY to $44 million, and consolidated net income attributable to HDI fell to $43 million from $377 million as the prior-year period included a one-time benefit from HDFS's sale of securitization interests and receivables.

• · LiveWire Group has withdrawn its guidance, and its recent disclosure flags substantial doubt about its ability to continue as a going concern.
• · Brake hose assembly quality and regulatory non-compliance issues involving supplier Proterial Cable America, Inc. are flagged as a risk factor.
• · Global dealer inventory fell 26% YoY and 6% QoQ, and 91% of North American dealer inventory is current MY2026 models (up from 86%).
• · Asia-Pacific retail grew only 1% overall, which is flat relative to the 5% global and 9% North American growth rates.
• · HDFS operating income margin of 9.7% compares to 168.0% in Q3 2025, reflecting the shift to an asset-light model after the prior-year sale of securitization interests and receivables.

29-10-2026

Criteo appointed Jianchang "JC" Mao, former Google Assistant and Microsoft Advertising executive, as an independent director effective October 28, 2026, while Edmond Mesrobian stepped down from the Board after nearly a decade of service, stating no disagreement with the Company. The change is presented as strengthening the Board's AI and advertising expertise ahead of the proposed U.S. Merger.

• · Mesrobian's departure was explicitly not due to any disagreement with the Company or Board on operations, policies, or practices
• · Mao is designated an independent director and is a Fellow of IEEE with a Ph.D. in computer science from Michigan State University
• · Mao's appointment is tied to the expected benefits of the proposed U.S. Merger, with a risk that he may not be appointed at the effective time of the merger

29-10-2026

Clorox announced that its Board appointed Fabian Garcia, current president of Unilever Personal Care, as CEO effective January 5, 2027, succeeding Linda Rendle, who is stepping down for health reasons. Garcia will join the Board at that time, and Matthew Shattock will become independent chair; Rendle will serve in an advisory capacity through April 2, 2027. The company also noted it will report first-quarter fiscal 2027 results on November 2, 2026.

• · Rendle will step down as CEO and director on Garcia's start date (January 5, 2027) and remain an advisor through April 2, 2027
• · Shattock, a former Board chair, returns to the role of independent chair
• · Rendle announced her departure in May 2026 citing health reasons
• · Garcia previously served as CEO of Revlon and COO for Global Innovation and Growth at Colgate-Palmolive, and currently sits on the Wells Fargo board

29-10-2026

NCL Corporation Ltd. (direct subsidiary of Norwegian Cruise Line Holdings) announced a CFO transition: Mark A. Kempa will step down as EVP, Chief Financial Officer, moving to Special Advisor to the CEO through June 30, 2027, while Meghan Montana, currently Chief Strategy Officer, will become EVP, CFO effective January 1, 2027. Montana's new employment agreement carries a $875,000 base salary and a $1,550,000 sign-on bonus, while Kempa's transition agreement provides a $3,200 monthly advisory salary and transition benefits.

• · Kempa's CFO role continues through December 31, 2026; his separation date is June 30, 2027, with non-compete/non-solicit running January 1, 2027 through December 31, 2028
• · Montana's employment agreement initial term runs through December 31, 2030, with automatic one-year renewals absent 60-day non-renewal notice
• · Montana's severance is 2x base salary paid over 24 months, plus prorated bonus, 18 months of benefits, and full equity acceleration on a change-in-control termination (within 3 months before or 24 months after)
• · Montana's sign-on bonus repayment applies if employment terminates before January 20, 2028, except for qualifying terminations
• · Montana previously served as SVP Finance and Corporate Development at American Airlines (February 2025 to January 2026) and as Treasurer at NCLH before that

29-10-2026

Opendoor Technologies Inc. (Nasdaq: OPEN) announced that Mike Alfred, Founder and Managing Partner of Alpine Fox LP and an existing Opendoor shareholder, was appointed to its Board of Directors effective October 29, 2026, and will also serve on the Nominating and Corporate Governance Committee. CEO Kaz Nejatian described Alfred as a builder and experienced investor, and the announcement contains no financial results, guidance, or quantitative performance data.

• · Alfred has served on the board of IREN Limited (Nasdaq: IREN), an AI data center developer and Bitcoin miner, since 2021, and on the board of Bakkt Holdings, Inc. (NYSE: BKKT) since 2025.
• · Alfred previously co-founded and was CEO of BrightScope, Inc. from 2008 until its acquisition by Strategic Insight, Inc. in 2016, and co-founded and was CEO of Digital Assets Data, Inc. until its sale to New York Digital Investment Group in 2020.
• · Alfred advises the CEO of Amenify Corporation, a real estate technology company, and sits on the boards of privately held Eaglebrook Advisors and Wealthie Inc.; he holds a B.A. in History from Stanford University.
• · Alfred is a shareholder of Opendoor through Alpine Fox LP, which may be relevant to governance and independence considerations.

29-10-2026

First Mid Bancshares, Inc. (NASDAQ: FMBH) entered a definitive agreement dated October 28, 2026 to acquire Evergreen Bancshares, Inc., parent of American Bank of Freedom, in a stock-and-cash merger valued at approximately $70.7 million based on FMBH's $51.01 closing price on October 27, 2026. The deal, approximately 80% stock and 20% cash, is projected to be 5.0% accretive to 2028 EPS and dilutive to tangible book value per share by approximately 0.5%, with an estimated 0.5-year earnback. Closing is expected in Q1 2027, subject to regulatory, Evergreen shareholder, and customary approvals, with the bank merger and systems conversion targeted for Q2 2027. Note that the transaction carries dilution to tangible book value and will push First Mid above the $10 billion asset threshold.

• · Deal structure is 0.4081 FMBH shares plus $5.20 cash per Evergreen share
• · Expansion into Indianapolis market via Westfield, Indiana banking center and existing loan production office in Denver, Colorado area
• · Transaction would take First Mid above $10 billion in assets, with management citing offsetting earnings and synergies
• · Evergreen is a privately held company, introducing risks around non-public financial information (noted in forward-looking statements)
• · Shareholder approval of Evergreen is required; FMBH will file a Form S-4 registration statement
• · Financial projections are illustrative and exclude share buybacks, restructuring charges, and CECL-related provision expense

29-10-2026

Norwegian Cruise Line Holdings (NCLH) announced a CFO succession: Mark A. Kempa will move from Executive Vice President, Chief Financial Officer to Special Advisor to the President and CEO after December 31, 2026, and his employment concludes June 30, 2027. Meghan Montana, currently Chief Strategy Officer (since January 2026), will become Executive Vice President, CFO effective January 1, 2027, with a new employment agreement carrying a $875,000 base salary and a $1,550,000 total sign-on bonus structure. The filing discloses severance and retirement terms for both executives but does not disclose any financial performance metrics.

• · Kempa's employment concludes June 30, 2027 (Separation Date), with 24-month non-compete and non-solicitation running January 1, 2027 through December 31, 2028
• · Kempa retains 2026 annual bonus eligibility and existing equity awards continue vesting; no new equity grants after the Transition Agreement
• · Montana's employment agreement initial term runs through December 31, 2030, auto-renewing annually absent 60 days' notice of non-renewal
• · Montana's retirement terms include accelerated vesting of time-based awards granted after January 1, 2027 and at least one year before retirement
• · Montana's change-in-control protection provides full accelerated equity vesting if terminated within three months before or 24 months after a change in control
• · Montana's first two sign-on installments are subject to clawback if employment ends before January 20, 2028, except for qualifying terminations
• · Montana previously held Treasurer roles (2018 to 2025) and American Airlines SVP Finance and Corporate Development (February 2025 to January 2026), and serves on the Azorra board and its Audit Committee

29-10-2026

Hilton Grand Vacations Inc. (NYSE:HGV) promoted Mike Riley to EVP, Chief Sales & Marketing Officer effective October 29, 2026, succeeding Dusty Tonkin, who will leave the Company effective April 1, 2027 after a transition period. Riley has been with HGV since 2012 (15 years) and brings more than 25 years of industry experience, most recently as senior vice president of sales.

• · Dusty Tonkin's departure is effective April 1, 2027, so the handover occurs after a transition period rather than immediately
• · Riley previously oversaw several of HGV's largest and highest-performing markets as SVP of Sales and played a key role in the new buyer growth strategy
• · CEO Mark Wang credited Riley with building high-performing teams and consistent execution

29-10-2026

Saia reported record third quarter 2026 revenue of $982.5 million (up 17.0% YoY) and record LTL tonnage per workday (up 8.9%), with diluted EPS of $3.41 versus $3.22 a year earlier (and $2.81 adjusted for a 2025 real estate gain). Operating income rose 3.1% to $122.3 million, but the operating ratio widened to 87.6% from 85.9% reported (flat versus the 87.6% adjusted prior-year figure), and LTL shipments per workday grew only 0.8%. The Board authorized a $250 million common stock repurchase program with no expiration date.

• · Operating ratio widened 170 bps YoY on a reported basis (85.9% to 87.6%), and the 9M 2026 operating ratio of 88.6% compares unfavorably to 88.2% reported (88.8% adjusted) in 9M 2025
• · Q3 2026 earnings growth was driven partly by a prior-year one-time real estate gain: adjusted EPS comparison shows 21.4% growth, but reported diluted EPS grew only 5.9%
• · Operating income grew only 3.1% reported, far below the 17.0% revenue growth, indicating cost pressure
• · LTL shipments per workday grew only 0.8%, so volume growth was largely tonnage-driven
• · Nine-month operating income of $314.3M and diluted EPS of $8.79 (vs $7.75 prior year) included no comparable gain adjustments in 2026
• · Q3 2025 gain on terminal sale ($16.4M) and real estate impairment ($1.9M) netted to a $14.5M operating income benefit in the prior-year base
• · Cash on hand rose to $202.5M from $35.5M while total debt fell to $100.0M from $219.2M year over year
• · Full-year 2026 net capex guidance of ~$350M is subject to ongoing evaluation of market conditions
• · Repurchase program has no expiration date and may be suspended or terminated at any time without notice

29-10-2026

INmune Bio (NASDAQ: INMB) announced pricing of a registered direct offering of 3,000,000 common shares plus a concurrent private placement of unregistered warrants for up to 3,000,000 shares, with expected gross proceeds of approximately $4.50 million before placement agent fees and expenses. Warrants carry an exercise price of $1.65, become exercisable six months after issuance, and expire 5.5 years from issuance; closing is expected on or about October 29, 2026, with A.G.P./Alliance Global Partners as sole placement agent. Proceeds are earmarked for working capital and general corporate purposes, and the company has committed to file a resale registration statement within 30 days of closing.

• · Warrant exercise price is $1.65 per share, exercisable six months after issuance and expiring 5.5 years from issuance
• · Offering is made under an effective Form S-3 shelf (File No. 333-279036) declared effective August 7, 2024; the warrants are issued under Section 4(a)(2) private placement exemption
• · Company agreed to file a resale registration statement within 30 days of the closing
• · XPro1595™ received FDA Fast Track designation and end-of-Phase 2 regulatory alignment
• · CORDStrom™ MAA planned for UK MHRA in Q1 2027 and EU EMA in 2027, with a planned U.S. BLA submission

29-10-2026

DoorDash, Inc. (NASDAQ: DASH) has entered into a definitive agreement to acquire Maplebear Inc. (Instacart, NASDAQ: CART) at $65.00 per share, an equity value of approximately $17 billion and a 26% premium to Instacart's October 22, 2026 closing price. The consideration will be at least 75% cash, with stock capped at 25% of aggregate consideration, and the deal is expected to close in late 2027 or the first half of 2028 subject to Instacart stockholder approval, HSR and other regulatory approvals, and customary conditions. DoorDash also reported its third quarter 2026 results the same day, though the filing excerpt does not include those quarterly figures.

• · Instacart stockholders may elect $65.00 cash, 0.3372 DoorDash shares, or a mix of $48.75 cash and 0.0843 DoorDash shares, subject to proration
• · DoorDash has a financing commitment letter with JPMorgan Chase Bank, N.A. for a 364-day senior unsecured bridge loan; the transaction is not subject to a financing condition
• · DoorDash targets a capital structure that maintains investment-grade credit ratings
• · Regulatory approvals required include HSR waiting period expiration plus clearances in Canada and Israel
• · DoorDash will hold an earnings call at 5:30 a.m. PT (8:30 a.m. ET) on October 29, 2026 to discuss Q3 2026 results and the transaction
• · Following closing, DoorDash expects to keep Instacart's brand, enterprise technology products, and app

29-10-2026

On October 23, 2026, Vice Chair and Chief Risk Officer Jodi L. Richard resigned effective immediately to take a position at another publicly traded company; the resignation was not due to any disagreement with the Company. Troy W. Remington, Executive Vice President and Chief Credit Officer, will serve as interim Chief Risk Officer while the Company selects a successor.

• · Resignation is not related to any disagreement with the Company on operations, policies, or practices
• · Resignation was effective immediately upon notice on October 23, 2026
• · Filing dated October 29, 2026, reports Items 5.02 and 9.01
• · Securities listed on NYSE include common stock (USB) and multiple preferred depositary shares and senior notes

29-10-2026

DoorDash, Inc. (NASDAQ: DASH) has entered into a definitive agreement to acquire Maplebear Inc. (d.b.a. Instacart, NASDAQ: CART) for $65.00 per share in cash or stock, valuing Instacart at approximately $17 billion, a 26% premium to its October 22, 2026 closing price. The consideration is at least 75% cash, with DoorDash stock capped at 25% of aggregate consideration, and the deal has unanimous Instacart board approval and support from holders of about 19% of outstanding shares. Closing is expected in late 2027 or the first half of 2028, subject to Instacart stockholder approval, HSR and other regulatory clearances (including Canada and Israel), and customary conditions.

• · Instacart stockholders may elect $65.00 cash, 0.3372 DoorDash shares, or a mix of $48.75 cash and 0.0843 DoorDash shares, subject to proration
• · Financing via cash on hand, debt proceeds, and a 364-day senior unsecured bridge loan facility from JPMorgan Chase Bank, N.A.; no financing condition; DoorDash targets maintaining investment-grade ratings
• · Deal is not subject to a financing condition
• · DoorDash commits to an open platform with no grocery exclusivity and to preserving Instacart's brand, enterprise technology products, and app post-close
• · Until closing, DoorDash and Instacart continue to operate as separate and independent companies
• · Concurrent Q3 2026 results were to be reported by DoorDash, with an earnings call and transaction discussion at 5:30 a.m. PT

29-10-2026

Mineralys Therapeutics terminated its July 2020 License Agreement with Tanabe Pharma on October 27, 2026, and had the patents and know-how for lorundrostat (Transferred Intellectual Property) assigned to it, eliminating the royalty-free license structure in favor of outright ownership. However, the company remains obligated under a new Payment Obligation Agreement to pay up to $255.0 million in commercial milestones plus up to $10.0 million for a second indication, and the prior $100.0 million change-of-control acceleration trigger no longer applies. No material early termination penalties were incurred, and Tanabe retains a right of first negotiation for Japan only.

• · License Agreement originally dated July 9, 2020, amended November 24, 2020, June 15, 2023, May 29, 2025, and June 2, 2026
• · Prior license was exclusive, worldwide, royalty-free, sublicensable, perpetual and irrevocable
• · Tanabe's right of first negotiation survives only with respect to Japan, for as long as any milestone remains unpaid
• · Full text of the Termination Agreement and Payment Obligation Agreement will be filed as exhibits to the Form 10-K for the year ending December 31, 2026
• · Company is an emerging growth company; common stock trades on Nasdaq under MLYS
• · Company incorporated in Delaware, IRS EIN 84-1966887, Commission File Number 001-41614
• · Principal executive offices: 150 N. Radnor Chester Road, Suite F200, Radnor, Pennsylvania 19087

29-10-2026

Lionsgate Studios Corp. disclosed in an 8-K that its Compensation Committee approved a three-month extension of CFO James W. Barge's employment agreement, pushing the term to January 31, 2027. The amendment, dated October 29, 2026, was approved October 28, 2026, and filed as Exhibit 10.1. No financial terms, compensation changes, or departure were disclosed, and the short extension signals a near-term CFO transition timeline rather than a long-term renewal.

• · Amendment approved by the Compensation Committee on October 28, 2026
• · Extended agreement term now runs through January 31, 2027
• · Amendment attached as Exhibit 10.1; cover page formatted in Inline XBRL (Exhibit 101)
• · Company incorporated in British Columbia, Canada; common shares trade on NYSE under ticker LION
• · Principal offices listed at 250 Howe Street, 20th Floor, Vancouver, BC and 2700 Colorado Avenue, Santa Monica, California

29-10-2026

ParkerVision appointed William G. Walters as a Class II director, expanding its board from four to five members. Walters is a retired investment banker focused on micro and small cap companies who raised over $3 billion across multiple IPOs, including Cheyenne Software, Take Two Interactive and Universal Display. The filing contains no financial results or period-over-period metrics; the company remains engaged in patent enforcement actions in the U.S.

• · Board expanded from four to five members to create the vacancy filled by Walters
• · Walters holds a Bachelor of Science in Economics from the Wharton School and a certificate from Harvard Business School's Owner/President Management (OPM) program
• · Walters remains an active investor in early stage companies
• · ParkerVision trades on OTCQB under ticker PRKR
• · Forward-looking statements reference risk factors in the Form 10-K for year ended December 31, 2025 and Form 10-Q for quarter ended March 31, 2026

29-10-2026

Sysco Holdings Corporation, a Delaware subsidiary of Sysco Corporation, executed Joinder No. 1 dated October 25, 2026 in favor of Bank of America, N.A. as Administrative Agent, joining the April 16, 2026 Credit Agreement as a Subsidiary Guarantor. The joinder was required under Section 5.09 of the Credit Agreement because the new subsidiary guarantees Sysco's Notes, and it unconditionally assumes all obligations of a Subsidiary Guarantor. The filing discloses no monetary amounts, pricing, or financial performance metrics, so there is no period-over-period comparison to report.

• · Credit Agreement dated as of April 16, 2026 among Sysco Corporation, Sysco Canada, Inc., Sysco Global Holdings B.V., Subsidiary Guarantors, Lenders, Issuing Banks and Bank of America, N.A. as Administrative Agent
• · Joinder No. 1 dated as of October 25, 2026; 8-K filed October 29, 2026
• · Joinder executed pursuant to Section 5.09(b) of the Credit Agreement, triggered because the new subsidiary guarantees the Notes
• · Representations and warranties other than Sections 3.04(b), 3.06 and 3.07 confirmed true and correct in all material respects as of the joinder date
• · Joinder governed by New York law; Sections 10.07, 10.09(b)-(d) and 10.10 of the Credit Agreement incorporated by reference
• · No fees, commitments, interest rates, or principal amounts disclosed in the exhibit

29-10-2026

Arch Capital Group Ltd. disclosed in an 8-K that director Moira Kilcoyne resigned from the Board effective October 26, 2026. The company stated the resignation was not due to any disagreement with Arch on operations, policies, or practices, and the Board thanked her for her service. No financial figures, guidance, or performance metrics were disclosed in the filing.

• · Resignation effective immediately on October 26, 2026; 8-K filed October 29, 2026
• · Company is incorporated in Bermuda (Commission File Number 001-16209)
• · Common shares trade on NASDAQ under ACGL; Series F and Series G depositary shares under ACGLON and ACGLN
• · Filing signed by François Morin as EVP, CFO and Treasurer
• · No replacement director or compensatory arrangement was disclosed

29-10-2026

Lafayette Square USA, Inc. entered into Amendment No. 3 to its Senior Secured Revolving Credit Agreement on October 27, 2026, increasing aggregate lender commitments from $300,000,000 to $315,000,000 (a 5.0% increase) and raising the accordion provision to permit total facility capacity of up to $600,000,000. The amendment, arranged with ING Capital LLC as Administrative Agent and City National Bank as Joint Lead Arranger, expands available borrowing capacity but does not disclose pricing, maturity, or covenant changes.

• · Original credit agreement dated June 18, 2024; previously amended September 20, 2024 (Amendment No. 1) and April 24, 2025 (Amendment No. 2)
• · ING Capital LLC serves as Administrative Agent, Joint Lead Arranger, Sole Bookrunner and Sustainability Structuring Agent
• · City National Bank serves as Joint Lead Arranger
• · Company is an emerging growth company and elected not to use the extended transition period for new accounting standards
• · No securities are registered under Section 12(b); no trading symbol or exchange listed
• · Amendment filed as Exhibit 10.1 with certain exhibits/schedules omitted under Item 601 of Regulation S-K
• · No pricing, maturity date, or covenant terms disclosed in the filing

29-10-2026

Outdoor Specialty Products, Inc. (ODRS) entered into a Stock Purchase Agreement dated October 22, 2026 with Quantum Qualified Opportunity Fund, LLC, under which Quantum will acquire 24,402,042 shares of common stock for $1,500,000 in cash, closing October 30, 2026, resulting in a change of control with Quantum owning approximately 95% of outstanding common stock. The deal includes cancellation of 4,000,000 principal stockholder shares in exchange for 100 shares of new Series A Preferred Stock, repayment of $226,792 in principal plus $21,216 accrued interest on insider notes, and a management overhaul (Dennis M. Danzik as President/Executive Chairman, Craig Kitchen as Secretary/Treasurer). However, closing remains subject to customary conditions with no assurance of completion, and the Series A Preferred Stock carries no voting, conversion, dividend, or liquidation preference rights.

• · Series A Preferred holders receive newly issued common shares equal to Registrant Issuance divided by 19 during the Protection Period
• · Series A Preferred Stock is non-voting with no conversion, dividend, or liquidation preference rights
• · Kirk Blosch to resign officer positions at closing and enter a six-month consulting agreement to manage the fishing products business
• · Director changes (Blosch resignation; Ker and Benloulou appointments) effective only after Rule 14F-1 compliance
• · Closing scheduled October 30, 2026, subject to customary conditions with no assurance of completion
• · Certificate of Designation for Series A Preferred to be filed with Nevada Secretary of State prior to closing

29-10-2026

Rivian reported Q3 2026 revenue of $2.155 billion, up 38% YoY, on record deliveries of 19,248 units (+46% YoY) as R2 became its best-selling vehicle. Consolidated gross profit improved $152 million to $176 million and net loss narrowed to $(913) million from $(1.173) billion, but gross margin slipped to 8% from 11% in Q2 2026, automotive gross profit remained negative at $(80) million, and free cash flow deteriorated sharply to $(1,124) million from $(421) million a year earlier. The company raised full-year delivery guidance to 67,000–70,000 units and improved Adjusted EBITDA and capex outlook, while also disclosing an executive change (Item 5.02) and the acquisition of Third Dimension AI.

• · Automotive gross profit loss narrowed to $(80) million from $(130) million YoY, but remains negative
• · Gross margin fell to 8% in Q3 2026 from 11% in Q2 2026 and 9% in Q4 2025/Q1 2026
• · Free cash flow worsened to $(1,124) million from $(421) million YoY; nine-month 2026 operating cash use was $(1,948) million vs $(98) million in 2025
• · Inventory rose to $1,779 million from $1,594 million at year-end 2025 to support R2 launch
• · FY2026 delivery guidance raised to 67,000–70,000 units from 65,000–70,000; Adjusted EBITDA improved $100 million at midpoint; capex cut $300 million at midpoint
• · Nine-month 2026 revenue was $5,194 million vs $4,101 million; net loss attributable to common stockholders narrowed to $(2,162) million from $(2,835) million
• · Rivian announced acquisition of Third Dimension AI to support closed-loop simulation
• · Item 5.02 indicates an officer change disclosed in the same 8-K
• · $506 million gain recognized in nine-month 2026 from Series A capital raise and deconsolidation of Mind Robotics
• · Adjusted operating expenses rose to $799 million from $783 million YoY

29-10-2026

Workhorse Group entered a strategic partnership with UK-based RHAELM to commercialize its new TerraPod modular data center platform, with RHAELM paying Workhorse $10 million under a Manufacturing Spec Unit Purchase Agreement to build a full-scale spec unit at its Union City, Indiana facility. A non-binding LOI targets a definitive Supply Agreement by December 31, 2026, framed to include a contingent initial order for 150 TerraPod systems and a U.S. right of first refusal. However, the LOI is non-binding, the 150-unit order is contingent on RHAELM acceptance and approvals, and Workhorse does not expect TerraPod production to begin until late 2027 or early 2028, leaving significant execution and financing risk.

• · TerraPod spec unit to be built at Workhorse's Union City, Indiana facility
• · Supply Agreement targeted for execution by December 31, 2026
• · Contemplated U.S. right of first refusal for Workhorse on all future RHAELM U.S. projects
• · Workhorse believes TerraPod production can begin in late 2027 or early 2028
• · LOI is non-binding; 150-unit order subject to definitive documentation and RHAELM internal approvals
• · Workhorse intends to become an official modular data center supply-chain provider to RHAELM's blueprint collaboration, subject to consortium partner consents

29-10-2026

Lennar Corporation entered into a Tenth Amended and Restated Credit Agreement dated October 26, 2026, providing a $3,795,000,000 revolving credit facility with JPMorgan Chase Bank, N.A. as Administrative Agent and Issuing Lender, replacing the Ninth Amended and Restated Credit Agreement dated November 25, 2024. Pricing is leverage-based, with Term Benchmark margins ranging from 1.625% (leverage >50%) down to 1.00% (leverage ≤15%), while investment-grade-rated borrowers receive a flat 1.00% Term Benchmark margin (0.90% at an improved investment grade rating). The filing contains no operating or financial performance data, so no period-over-period comparisons are available.

• · Credit agreement dated as of October 26, 2026; 8-K filed October 29, 2026
• · Replaces the Ninth Amended and Restated Credit Agreement dated November 25, 2024
• · JPMorgan Chase Bank, N.A. serves as Administrative Agent and Issuing Lender
• · Joint Bookrunners: JPMorgan Chase Bank, N.A., BofA Securities, Inc., and Mizuho Bank, Ltd.
• · Syndication Agents: Bank of America, N.A. and Mizuho Bank, Ltd.
• · ABR defined as greatest of Prime Rate, NYFRB Rate plus 0.5%, or one-month Adjusted Term SOFR plus 1%, with a 1.00% floor
• · Class B Revolving Loan pricing grid has a lower top tier (≤25% leverage at 1.10% Term Benchmark margin) than Class A/C (≤15% at 1.00%)
• · Pricing changes from leverage ratio changes take effect three business days after delivery of the Compliance Certificate
• · Includes letter of credit sub-facility provisions and an accordion feature for commitment increases (Section 2.21)
• · Financial condition covenants and negative covenants (liens, fundamental changes, investments) are set out in Section 7

29-10-2026

United Rentals (North America), Inc., as Borrowers' Agent, entered into Amendment No. 1 to its Fifth Amended and Restated Credit Agreement dated October 23, 2026, modifying subsidiary guarantee provisions and releasing three Specified U.S. Subsidiaries (United Rentals (Delaware), Inc., United Rentals Highway Technologies Gulf, LLC, and United Rentals Realty, LLC) from their guarantor obligations. The amendment also designates certain ROW Borrowers as Additional Designated European Borrowers and increases the European Swingline Sublimit to $40,000,000. The filing is a routine credit facility maintenance action with no reported financial performance metrics or period-over-period comparisons.

• · Amendment dated October 23, 2026; original Fifth Amended and Restated Credit Agreement dated July 10, 2025
• · Release of Specified U.S. Subsidiaries is automatic once each would no longer be required to become a Guarantor under Section 7.16(a)
• · Required Lenders consented to the release and authorized the Agent to file termination/release documents
• · Borrowers' Agent reaffirmed all guarantees, pledges and security interests remain in full force and effect
• · Effectiveness conditioned on KYC documentation for each Specified Additional Designated European Borrower and expense reimbursement to the Agent

29-10-2026

Alpine Income Property Trust (NYSE: PINE) closed $175 million in unsecured financings: a new $100 million 2030 Term Loan due October 2030 and a $75 million increase in Revolving Credit Facility commitments to $325 million from $250 million. The 2030 Term Loan carries an initial fixed rate of approximately 4.6% after moving $100 million of existing SOFR swaps from the revolver, though $50 million of those swaps mature in January 2027 and the remaining $50 million in March 2028, requiring future hedging decisions. The facilities were provided by a bank syndicate led by Truist Bank as administrative agent, with Capital One and Associated Bank newly joining the credit facility.

• · Truist Bank, N.A. serves as administrative agent for the syndicate
• · Capital One and Associated Bank are new participants in the credit facility
• · $50 million of SOFR swaps on the term loan mature in January 2027, creating near-term refinancing/hedging exposure
• · Remaining $50 million of SOFR swaps mature in March 2028
• · Company will continue evaluating interest rate hedging alternatives
• · Proceeds intended to fund future acquisitions and add liquidity/financial flexibility

29-10-2026

Dot Ai (CID HoldCo, Inc., Nasdaq: DAIC) announced that the Nasdaq Hearings Panel granted its request for continued listing, subject to transferring its listing to The Nasdaq Capital Market by November 2, 2026. The decision follows completion of the Envoy Technologies acquisition and Nasdaq's confirmation that the company regained compliance with the shareholders' equity requirement, after filing its Form 10-Q for the quarter ended June 30, 2026. However, continued listing remains conditional on the timely transfer application and ongoing compliance, and the company notes risks that approvals may not be obtained or compliance may not be maintained.

• · Deadline to submit application to transfer listing to The Nasdaq Capital Market: on or before November 2, 2026
• · Company filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026
• · Definitive proxy statement for 2026 annual meeting filed with SEC on April 17, 2026
• · Annual Report on Form 10-K for fiscal year ended December 31, 2025 filed with SEC on March 11, 2026
• · Company intends to file a proxy statement with the SEC in connection with proposed transactions
• · Media contact phone listed as 1347-839-0993

29-10-2026

Floor & Decor reported Q3 fiscal 2026 net sales of $1,214.6 million, up 3.0% YoY from $1,179.5 million, while comparable store sales declined 1.4%. Profitability improved sharply with net income up 13.2% to $64.8 million and diluted EPS up 15.1% to $0.61, but the top-line growth was driven by new store openings rather than existing stores. For the 39-week period, net sales rose 1.8% to $3,617.1 million with comps down 2.4%, and adjusted net income fell 1.1% to $167.5 million (adjusted diluted EPS down 0.6% to $1.55), highlighting mixed underlying performance.

• · Q3 gross profit rose 3.8% to $531.3 million with gross margin of 43.7% vs 43.4% prior year
• · Q3 SG&A expenses grew 3.0% to $453.3 million, holding at 37.3% of net sales
• · Q3 interest income of $0.382 million vs prior-year interest expense of $0.591 million
• · 39-week gross margin expanded 170 bps to 45.4% from 43.7%, while adjusted gross margin rose only 10 bps to 43.8%
• · 39-week SG&A rose 4.0% to $1,387.5 million, increasing to 38.4% of net sales from 37.6%
• · 39-week loss on extinguishment of debt of $1.328 million recorded
• · Diluted weighted average shares fell to 106.7 million in Q3 from 108.5 million, aided by $91.4 million of buybacks
• · FY2026 guidance: diluted EPS of $2.19-$2.29 and adjusted diluted EPS of $1.88-$1.98, with 53rd week adding ~$0.08
• · FY2026 guidance assumes tax rate of 21.5%-22.0% and net interest expense of approximately zero
• · Cash and cash equivalents rose to $392.5 million from $249.3 million at December 25, 2025
• · Inventories increased to $1,173.1 million from $1,133.1 million at year-end
• · Total assets grew to $5,716.2 million from $5,469.4 million at December 25, 2025
• · Conference call scheduled October 29, 2026 at 5:00 p.m. ET; replay available until November 5, 2026